Green tea polyphenol epigallocatechin-3-gallate (EGCG) as adjuvant in cancer therapy.
about
Epigallocatechin Gallate Nanodelivery Systems for Cancer TherapyDate (Phoenix dactylifera) Polyphenolics and Other Bioactive Compounds: A Traditional Islamic Remedy's Potential in Prevention of Cell Damage, Cancer Therapeutics and BeyondAntioxidant Intake and Antitumor Therapy: Toward Nutritional Recommendations for Optimal ResultsCancer Preventive Activities of Tea CatechinsMitochondrial modulation by Epigallocatechin 3-Gallate ameliorates cisplatin induced renal injury through decreasing oxidative/nitrative stress, inflammation and NF-kB in micePII Protein-Derived FRET Sensors for Quantification and Live-Cell Imaging of 2-Oxoglutarate.Effects of physiological levels of the green tea extract epigallocatechin-3-gallate on breast cancer cellsEGCG Enhances Cisplatin Sensitivity by Regulating Expression of the Copper and Cisplatin Influx Transporter CTR1 in Ovary CancerThe green tea catechin epigallocatechin gallate induces cell cycle arrest and shows potential synergism with cisplatin in biliary tract cancer cells.Green Tea Polyphenol Induces Changes in Cancer-Related Factors in an Animal Model of Bladder CancerEpigallocatechin-3-gallate rescues LPS-impaired adult hippocampal neurogenesis through suppressing the TLR4-NF-κB signaling pathway in mice.Epigallocatechin Gallate-Mediated Alteration of the MicroRNA Expression Profile in 5α-Dihydrotestosterone-Treated Human Dermal Papilla CellsIn vitro and in vivo study of epigallocatechin-3-gallate-induced apoptosis in aerobic glycolytic hepatocellular carcinoma cells involving inhibition of phosphofructokinase activity.Fractionated radiation exposure amplifies the radioresistant nature of prostate cancer cells.Preparation and characterization of (-)-Epigallocatechin-3-gallate (EGCG)-loaded nanoparticles and their inhibitory effects on Human breast cancer MCF-7 cells.In vitro evaluation of combination of EGCG and Erlotinib with classical chemotherapeutics on JAR cells.The Antiproliferative Effect of Chakasaponins I and II, Floratheasaponin A, and Epigallocatechin 3-O-Gallate Isolated from Camellia sinensis on Human Digestive Tract Carcinoma Cell Lines.Pyrogallol, an absorbable microbial gallotannins-metabolite and mango polyphenols (Mangifera Indica L.) suppress breast cancer ductal carcinoma in situ proliferation in vitro.An anthraquinone derivative from Luffa acutangula induces apoptosis in human lung cancer cell line NCI-H460 through p53-dependent pathway.Metabolic syndrome and prostatic disease: potentially role of polyphenols in preventive strategies. A review.Development of novel radiochemotherapy approaches targeting prostate tumor progenitor cells using nanohybrids.Inhibition of Myeloid Cell Leukemia 1 and Activation of Caspases Are Critically Involved in Gallotannin-induced Apoptosis in Prostate Cancer Cells.EGCG enhances the efficacy of cisplatin by downregulating hsa-miR-98-5p in NSCLC A549 cells.Mechanisms and therapeutic prospects of polyphenols as modulators of the aryl hydrocarbon receptor.Rutin, a Quercetin Glycoside, Restores Chemosensitivity in Human Breast Cancer Cells.Therapeutic Potential of Epigallocatechin Gallate Nanodelivery SystemsPhytotherapy and Nutritional Supplements on Breast CancerGreen Tea Extracts Epigallocatechin-3-gallate for Different Treatments.The effect of epigallocatechin-3-gallate on the renal dysfunction in the obstructed kidney in the rat.EGFR inhibition by (-)-epigallocatechin-3-gallate and IIF treatments reduces breast cancer cell invasion.The effect of (-)-epigallocatechin 3-O--gallate in vitro and in vivo in Leishmania braziliensis: involvement of reactive oxygen species as a mechanism of action.Protective effect of (-)-epigallocatechin-3-gallate on capsaicin-induced DNA damage and oxidative stress in human erythrocyes and leucocytes in vitro.Neuroprotective action of tea polyphenols on oxidative stress-induced apoptosis through the activation of the TrkB/CREB/BDNF pathway and Keap1/Nrf2 signaling pathway in SH-SY5Y cells and mice brain.Reversal of 5-fluorouracil resistance by EGCG is mediate by inactivation of TFAP2A/VEGF signaling pathway and down-regulation of MDR-1 and P-gp expression in gastric cancer.pH-Responsive Nanoscale Coordination Polymer for Efficient Drug Delivery and Real-Time Release Monitoring.Perspective: Neuroregenerative Nutrition.Enhancement of cisplatin cytotoxicity by Retigeric acid B involves blocking DNA repair and activating DR5 in prostate cancer cells.Antiangiogenic Effect of Flavonoids and Chalcones: An Update.Ameliorated Effects of (-)-Epigallocatechin Gallate Against Toxicity Induced by Vanadium in the Kidneys of Wistar Rats.Effects of an antioxidant beverage on biomarkers of oxidative stress in Alzheimer's patients.
P2860
Q26746909-4398EC2D-9660-4BF6-8F72-B4DA6FE61D0CQ26773409-084918BB-806D-47B0-839A-15BCD416CAA8Q26774897-6C166F30-9F68-48E3-A6EA-98BD1672A68CQ28076334-51E41EC9-CFA3-419C-8AD3-414FE2BD5BADQ28546437-E99D004F-BA94-4C60-8C57-6090B7D12969Q29994847-9A338E9F-EA13-4CF9-B1A7-5E85BFF016E5Q33605964-3EAA1D08-6DC5-4869-A6C8-B632E84ED6D2Q35558444-837503A3-E654-4C17-BC80-F8F42CA7F0F8Q35671261-54E92E30-59AF-4D44-A95A-B605D0BB757EQ36265124-DF731990-8A9F-4BDF-A20A-0845A81B145FQ36488674-E2056BAD-C078-41F8-90B5-A3F29A43192CQ36946003-D08A8FA2-A7D9-45C7-B429-3B2571B26819Q37044525-A3D1AB34-DA23-413E-83EE-19C2574DDCE3Q37310865-99FA6A63-5A17-490C-B767-7E50643CD92CQ37723926-64BA5C33-FD10-45FD-B827-FEAE2CEC499BQ38705254-73581921-59AA-4CF0-9071-52831D766482Q38728433-7DDF7E75-B54E-458F-8730-19E304CB783DQ38753801-2F7E8EB7-65DB-4397-946C-D238DA111BB2Q38818345-3ADF3938-E72C-4BBF-88DE-2666FC8BAE3CQ38861273-646AEC1D-DB3E-4D4D-AE7C-FB7166D572F6Q38865548-BC3560C6-548C-4993-BD9A-BB13DB6CFF7AQ38870589-AE9636D5-A688-431C-8C68-65FF4E4D17CBQ39006577-27A897A1-CF9A-41A9-B945-C3AE38E86E75Q39176010-A9F0E247-DD4A-4F21-9941-66DBC530578FQ40104498-A68D8E1E-D98E-4BD0-9D9E-C4C6D660F32AQ41169121-D637E687-7B4F-4653-A4FE-90214F30DC51Q41463405-CA1BF432-30BD-40FF-9C86-1DA19CBE15F0Q41528628-2BCFBF98-84B6-4443-8E62-2436BB87648EQ41658806-F7835D36-129D-4B12-AF6A-498873EF2920Q41818660-CC1F81CA-BE65-484F-9B4A-7FFA2B578C8AQ42829637-F8820B7D-D735-4CAD-A5DF-F7860E29F685Q43147938-0F8DCF79-13EA-4523-B7EA-DC98EA8BC29DQ47393366-B20E6780-9994-412E-835B-5169D959210BQ47403641-2A3F473F-6FB9-4EE0-8BD4-B7C6F4343C72Q48117650-70AE5450-641C-4517-AEA1-1D8C85DF70CDQ48194917-E75F9AFC-33E7-44F3-ACC0-603DE4E42008Q49479651-88365B61-7A04-4AFD-A43C-A3FAA6F2A8C6Q50043004-5D913413-DF6E-4541-A75D-E58ABF7939FCQ50204958-C5EF07FF-E029-4E33-8BDB-3EF97E3624F2Q50248146-907F6EA6-1785-41EE-87C7-8201BDDE0A55
P2860
Green tea polyphenol epigallocatechin-3-gallate (EGCG) as adjuvant in cancer therapy.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Green tea polyphenol epigallocatechin-3-gallate (EGCG) as adjuvant in cancer therapy.
@en
type
label
Green tea polyphenol epigallocatechin-3-gallate (EGCG) as adjuvant in cancer therapy.
@en
prefLabel
Green tea polyphenol epigallocatechin-3-gallate (EGCG) as adjuvant in cancer therapy.
@en
P2093
P1433
P1476
Green tea polyphenol epigallocatechin-3-gallate (EGCG) as adjuvant in cancer therapy.
@en
P2093
Claude Pichard
Elena Lecumberri
Raymond Miralbell
Yves Marc Dupertuis
P304
P356
10.1016/J.CLNU.2013.03.008
P577
2013-03-15T00:00:00Z